Skip to main content

Peer Review reports

From: Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot

Original Submission
21 Aug 2017 Submitted Original manuscript
15 Sep 2017 Author responded Author comments - Karin Beelen
Resubmission - Version 2
15 Sep 2017 Submitted Manuscript version 2
23 Mar 2018 Author responded Author comments - Karin Beelen
2 Jan 2018 Reviewed Reviewer Report - Adam Brufsky
10 Dec 2017 Reviewed Reviewer Report - Ellen Warner
10 Jan 2018 Reviewed Reviewer Report - Monika Klinkhammer-Schalke
Resubmission - Version 3
23 Mar 2018 Submitted Manuscript version 3
9 Apr 2018 Author responded Author comments - Karin Beelen
26 Mar 2018 Reviewed Reviewer Report - Adam Brufsky
27 Mar 2018 Reviewed Reviewer Report - Ellen Warner
Resubmission - Version 4
9 Apr 2018 Submitted Manuscript version 4
16 May 2018 Author responded Author comments - Karin Beelen
8 May 2018 Reviewed Reviewer Report - Ellen Warner
Resubmission - Version 5
16 May 2018 Submitted Manuscript version 5
Publishing
18 May 2018 Editorially accepted
24 Jul 2018 Article published 10.1186/s12885-018-4516-1

You can find further information about peer review here.

Back to article page
\